The Globe and Mail reports in its Wednesday, Nov. 29, edition that Barclays analyst Matthew Miksic has reaffirmed his "equal weight" recommendation for Bausch + Lomb. The Globe's David Leeder writes in the Eye On Equities column that Mr. Miksic gave his share target a $2 (U.S.) trim to $17 (U.S.). Analysts on average target the shares at $20.09 (U.S.). Mr. Miksic says in a note, "We have made a number of changes to our model, including the impact of tougher FX headwinds, higher interest expense and a higher projected tax rate." The Globe reported on July 27, 2022, Feb. 16, 2023, and Oct. 4, 2023, that RBC Dominion Securities analyst Douglas Miehm rated Bausch + Lomb "outperform." The shares could then be had for $14.50 (U.S.), $19 (U.S.) and $16.17 (U.S.).